Kane Biotech Announces FDA 510(k) Clearance for revyve® Antimicrobial Skin and Wound Cleanser Feb 17, 2026
Kane Biotech Announces Closing of Private Placement Offering with an Insider of the Company Dec 18, 2025
Kane Biotech Completes U.S. FDA 510(k) Submission for revyve® Antimicrobial Wound Cleanser Sep 16, 2025
